ӳý and Denmark-based scientists are collaborating to scale up their efforts to turn genetic insights into the fundamental biological mechanisms underlying metabolic disease.
The Novo Nordisk Foundation Center for Genomic Mechanisms of Disease brings together Danish and ӳý scientists. Managing director Kasper Lage shares the center’s origin story, its achievements so far, and what the future holds.
Scientists have engineered an adeno-associated virus (AAV) that efficiently crosses the blood-brain barrier in human cell models and delivers genes throughout the brain in humanized mice.
Tightly synchronized genetic changes in two types of brain cells may underlie cognitive impairment in both conditions, offering potential therapeutic clues.
Ralda Nehme, director of ӳý’s stem cell program, talks about how stem cells can be a model for disease in a dish and what scientists can learn from these experiments.
A low-cost CRISPR-based paper strip test distinguishes between influenza types and can be reprogrammed to recognize different viruses including the H5N1 bird flu virus.
Scientists from the US and West Africa have teamed up to build a better public health network that can quickly detect and respond to emerging viral threats.
In a pilot study with patient samples, the technology performed as well as the current gold-standard methods, yielding accurate results within hours instead of days.
Myocarditis is driven by a different immune response than the anti-tumor one, suggesting that the serious complication could one day be managed without halting cancer therapy.
Studies from the Zoonomia Project pinpoint key parts of the human genome that have remained unchanged after millions of years of evolution and may shed light on disease and unusual traits.
A study of tumor exomes reconstructs a timeline of mutations for certain cancer types, revealing insight into the order of genetic drivers of the disease.
Researchers have developed a technology, FALCON, to analyze the effects of free fatty acids in any cell type, and found type 2 diabetes genes that may further boost diabetes risk when cells are in a high-fat environment.
By integrating clinical, genetic, and other data from patients with lung cancer, researchers identify biological factors that could help predict treatment outcomes.